KABIR, A. . BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Bangladesh Journal of Medicine, [S. l.], v. 35, n. 20, p. 165, 2024. DOI: 10.3329/bjm.v35i20.73432. Disponível em: https://banglajol.info/index.php/BJMED/article/view/73432. Acesso em: 17 jul. 2024.